Endovia Health Sciences, Inc. (EDVA) stock
EDVANYSEBeveragesFiscal year ends December 31
$0.17−0.00 (-1.46%)
Close on Nov 17, 2026Market cap $126.28KP/E –Yield –
Endovia Health Sciences revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Endovia Health Sciences's revenue for the twelve months ending Sep 30, 2025 was $1.42M, down 77.4% year over year. For fiscal 2025 it was $73.07K, down 90.9% from the year before. Over ten years it grew -22.2% a year on average. The highest annual figure on record is $18.85M in fiscal 2023.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $73.07K | -90.9% |
| FY2024 | Dec 31, 2024 | $801.27K | -95.7% |
| FY2023 | Dec 31, 2023 | $18.85M | +4.2% |
| FY2022 | Dec 31, 2022 | $18.09M | +59.8% |
| FY2021 | Dec 31, 2021 | $11.32M | +392.0% |
| FY2020 | Dec 31, 2020 | $2.30M | +11182.3% |
| FY2019 | Dec 31, 2019 | $20.39K | -98.4% |
| FY2018 | Dec 31, 2018 | $1.31M | +46.2% |
| FY2017 | Dec 31, 2017 | $895.35K | -11.6% |
| FY2016 | Dec 31, 2016 | $1.01M | +12.8% |
| FY2015 | Dec 31, 2015 | $897.34K | +48.1% |
| FY2014 | Dec 31, 2014 | $605.91K | +27.5% |
| FY2013 | Dec 31, 2013 | $475.25K | +53.9% |
| FY2012 | Dec 31, 2012 | $308.73K | +8.8% |
| FY2011 | Dec 31, 2011 | $283.83K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0 | -100.0% |
| Q1 FY2026 | Mar 31, 2026 | $4.22K | -99.3% |
| Q3 FY2025 | Sep 30, 2025 | $393.07K | -60.0% |
| Q2 FY2025 | Jun 30, 2025 | $369.67K | -64.7% |
| Q1 FY2025 | Mar 31, 2025 | $68.61K | -95.5% |
| Q4 FY2024 | Dec 31, 2024 | $585.89K | -78.2% |
| Q3 FY2024 | Sep 30, 2024 | $981.86K | -80.9% |
| Q2 FY2024 | Jun 30, 2024 | $1.05M | -78.2% |
| Q1 FY2024 | Mar 31, 2024 | $1.54M | -68.4% |
| Q4 FY2023 | Dec 31, 2023 | $2.69M | -40.2% |
| Q3 FY2023 | Sep 30, 2023 | $5.14M | +31.0% |
| Q4 FY2022 | Dec 31, 2022 | $4.79M | +56.5% |
| Q3 FY2022 | Sep 30, 2022 | $4.87M | +72.3% |
| Q2 FY2022 | Jun 30, 2022 | $4.50M | +36.8% |
| Q1 FY2022 | Mar 31, 2022 | $3.93M | +83.6% |
| Q4 FY2021 | Dec 31, 2021 | $3.06M | +182.9% |
| Q3 FY2021 | Sep 30, 2021 | $2.83M | +308.0% |
| Q2 FY2021 | Jun 30, 2021 | $3.29M | +696.6% |
| Q1 FY2021 | Mar 31, 2021 | $2.14M | +1809.7% |
| Q4 FY2020 | Dec 31, 2020 | $1.08M | +11.5% |
| Q3 FY2020 | Sep 30, 2020 | $692.97K | +127.1% |
| Q2 FY2020 | Jun 30, 2020 | $412.73K | +864.9% |
| Q1 FY2020 | Mar 31, 2020 | $112.00K | +4102.7% |
| Q4 FY2019 | Dec 31, 2019 | $970.75K | +227.1% |
| Q3 FY2019 | Sep 30, 2019 | $305.20K | -2.5% |
| Q2 FY2019 | Jun 30, 2019 | $42.78K | -87.9% |
| Q1 FY2019 | Mar 31, 2019 | $2.67K | -99.2% |
| Q4 FY2018 | Dec 31, 2018 | $296.80K | +90.6% |
| Q3 FY2018 | Sep 30, 2018 | $312.99K | -1.9% |
| Q2 FY2018 | Jun 30, 2018 | $354.77K | +68.5% |
| Q1 FY2018 | Mar 31, 2018 | $344.62K | +64.1% |
| Q4 FY2017 | Dec 31, 2017 | $155.70K | -50.8% |
| Q3 FY2017 | Sep 30, 2017 | $319.02K | +35.1% |
| Q2 FY2017 | Jun 30, 2017 | $210.57K | -10.8% |
| Q1 FY2017 | Mar 31, 2017 | $210.06K | – |
| Q4 FY2016 | Dec 31, 2016 | $316.59K | – |
| Q3 FY2016 | Sep 30, 2016 | $236.06K | – |
| Q2 FY2016 | Jun 30, 2016 | $236.06K | – |
See a number that looks wrong?